Repligen (RGEN) financial statements
Repligen reported revenue of $738M in fiscal 2025, up 24.3% a year over 9 years.
Net income was $49M and the operating margin 7.5%, against 15.3% in 2016.
Free cash flow was $94M.
The diluted share count rose 66% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Repligen's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $105M | $141M | $194M | $270M | $366M | $671M | $802M | $632M | $634M | $738M |
| Cost of revenue | $47M | $67M | $87M | $119M | $157M | $279M | $346M | $354M | $360M | $352M |
| Gross profit | $57M | $74M | $108M | $151M | $210M | $391M | $456M | $278M | $275M | $386M |
| Research and development | $7M | $9M | $16M | $19M | $20M | $34M | $44M | $43M | $43M | $54M |
| Selling, general and admin | $31M | $52M | $66M | $96M | $120M | $184M | $216M | $219M | $263M | $291M |
| Operating income | $16M | $14M | $26M | $36M | $70M | $167M | $225M | $48M | -$35M | $55M |
| Interest expense | $4M | $6M | $7M | $9M | $11M | $11M | $1M | $2M | $21M | $22M |
| Pre-tax income | $12M | $7M | $21M | $26M | $59M | $154M | $219M | $57M | -$27M | $62M |
| Income tax | $11,000 | -$21M | $5M | $5M | -$709,000 | $25M | $33M | $21M | -$2M | $13M |
| Net income | $12M | $28M | $17M | $21M | $60M | $128M | $186M | $36M | -$26M | $49M |
| EPS (diluted) | $0.34 | $0.72 | $0.37 | $0.44 | $1.11 | $2.24 | $3.24 | $0.63 | -$0.46 | $0.86 |
| Diluted shares | 34M | 39M | 45M | 49M | 54M | 57M | 57M | 56M | 56M | 57M |
| Gross margin | 54.9% | 52.5% | 55.4% | 55.9% | 57.2% | 58.3% | 56.9% | 44.0% | 43.3% | 52.3% |
| Operating margin | 15.3% | 9.9% | 13.4% | 13.4% | 19.1% | 24.9% | 28.0% | 7.5% | -5.5% | 7.5% |
| Net margin | 11.2% | 20.1% | 8.6% | 7.9% | 16.4% | 19.1% | 23.2% | 5.6% | -4.0% | 6.6% |
Balance sheet
Fiscal years, from Repligen's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $142M | $174M | $194M | $528M | $717M | $604M | $523M | $751M | $757M | $768M |
| Receivables | $15M | $28M | $33M | $43M | $71M | $117M | $116M | $124M | $134M | $159M |
| Inventory | $25M | $39M | $42M | $55M | $95M | $184M | $238M | $202M | $143M | $170M |
| Total current assets | $184M | $243M | $276M | $642M | $902M | $932M | $998M | $1.1B | $1.1B | $1.1B |
| Property, plant and equipment | $15M | $22M | $32M | $48M | $67M | $125M | $191M | $207M | $198M | $187M |
| Goodwill | $60M | $327M | $327M | $468M | $618M | $860M | $856M | $987M | $1.0B | $1.1B |
| Total assets | $289M | $744M | $775M | $1.4B | $1.9B | $2.4B | $2.5B | $2.8B | $2.8B | $2.9B |
| Total current liabilities | $21M | $25M | $130M | $48M | $319M | $375M | $404M | $165M | $127M | $136M |
| Total liabilities | $120M | $152M | $159M | $340M | $374M | $608M | $621M | $866M | $857M | $844M |
| Shareholders' equity | $169M | $592M | $616M | $1.1B | $1.5B | $1.8B | $1.9B | $2.0B | $2.0B | $2.1B |
| Net debt | -$122M | -$174M | -$194M | -$528M | -$717M | -$604M | -$523M | -$751M | -$757M | -$566M |
Cash flow
Fiscal years, from Repligen's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $8M | $17M | $33M | $67M | $63M | $119M | $172M | $114M | $175M | $117M |
| Capital spending | $4M | $5M | $12M | $19M | $22M | $67M | $85M | $36M | $26M | $24M |
| Free cash flow | $3M | $12M | $21M | $49M | $40M | $52M | $87M | $78M | $150M | $94M |
| Stock-based compensation | $5M | $7M | $10M | $13M | $17M | $28M | $27M | $26M | $48M | $33M |
| Share buybacks (net) | — | — | — | — | — | $0 | $0 | -$14M | $0 | $0 |
| Free cash flow margin | 3.1% | 8.5% | 10.8% | 18.0% | 11.0% | 7.7% | 10.9% | 12.3% | 23.6% | 12.7% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for RGEN.
Open RGEN in InvestinglyQuestions
What was Repligen's revenue in 2025?
$738M in fiscal 2025, from its 10-K filing.
How much free cash flow does Repligen generate?
$94M in fiscal 2025 (operating cash flow minus capital spending).
From Repligen's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.